We can't afford much more price erosion given the approved RS range and that is why I believe an uplist may be upon us sooner rather than later as some have suggested. The 'back' of the downward spiral must be broken soon and management knows that, imo.
Quite possible, but Rabin said we would only move under a position of strength. Ideally that strength would be announcement of JV(s)riding on the back of continued spectacular clinical results. I think that is more likely to happen later in the year. JMHO, I've been wrong lots of times before
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.